Loading clinical trials...

Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge | Clinical Trials | Clareo Health

TERMINATEDNA

Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

The Utilization of Virtual Reality Technology Versus Standard of Care During Pediatric Oral Food Challenge: a Pilot Study

NCT04376242•Stanford University

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care of utilizing existing technologies that are currently more common in food allergy research treatment and clinics (i.e. television and patients' personal electronic devices) for decreasing levels anxiety and fear in pediatric patients undergoing oral food challenge (OFC) and their caregivers.

Eligibility

Age

5 - 17 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Between the ages of 5 and 17
•Willing to participate in both the VR and standard of care technology conditions
•Able to consent or have parental consent
•Undergoing at least two Oral Food Challenges within the window of recruitment at the Sean N. Parker Center

Exclusion Criteria

•People who do not consent
•Significant Cognitive Impairment
•History of Severe Motion Sickness
•Current Nausea
•Seizures
•Visual Problems
•Non-English Speaking
•Patients who clinically unstable or requires urgent/emergent intervention
•ASA class 4 or higher

Locations (1)

Stanford University

Stanford, California, United States

Key Dates

Start Date

February 1, 2021

Primary Completion Date

September 30, 2022

Completion Date

September 30, 2022

Last Updated

January 20, 2025

Enrollment

ACTUAL participants

Conditions

Food Allergy in ChildrenFood Allergy

Interventions

use of virtual reality

BEHAVIORAL

use of standard technology

BEHAVIORAL

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

NCT00267501

Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory DiseaseFood Allergy

View study

RECRUITINGNA

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

NCT06260956

Allergy and ImmunologyPeanut and Nut Allergy+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

Inclusion Criteria

Exclusion Criteria

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

Evaluation of The Food Allergy Mastery Program

Effect of Omalizumab in the Skin of Food Allergy Patients

The NACHO Trial (Nut Allergy Children OIT)

EPAP, Interviewstudy